EGFR and hepatocellular carcinoma: This is important because monoamine oxidase was found to suppress HCC metastasis and progression by inhibiting the adrenergic system and its transactivation of epidermal growth factor receptor (EGFR) signalling [21,22,23,24,25,26,27,28,29,30].